CytoDyn Market Cap

CytoDyn has a market cap or net worth of $419.67 million as of April 29, 2026. Its market cap has increased by 56.98% in one year.

Market Cap

419.67M

Enterprise Value

432.84M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.31

Market Cap Chart

Since November 17, 2005, CytoDyn's market cap has increased from 5.54M to 419.67M, an increase of 7,478.65%. That is a compound annual growth rate of 23.56%.

Market Cap History

Date	Market Cap	% Change
Apr 27, 2026	436.45M	22.73%
Dec 31, 2025	355.63M	164.14%
Dec 31, 2024	134.63M	-29.42%
Dec 29, 2023	190.74M	2.63%
Dec 30, 2022	185.85M	-72.64%
Dec 31, 2021	679.28M	-78.86%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Silence Therapeutics	363.70M
Northwest Biotherapeutics	330.27M
Vaxart	173.64M
Glorywin Entertainment Group	149.60M
NDT Pharmaceuticals	112.60M
Viskase Holdings	95.20M
HST Global	88.40M
BioStem Technologies	81.91M

Market Cap Rankings